A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

Interest in weight-loss medications is at an all-time high, with promising study results and inspiring success stories coming ...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy ... in adults with a body mass index (BMI) of 27 kg/m² or greater, who have established cardiovascular disease.

If you’ve been debating starting a weight-loss treatment like tirzepatide or semaglutide ... tiredness/lack of energy, and injection site reactions. In more advanced cases, the weight-loss ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

In a recent study, participants taking orforglipron lost up to 14.7% of their body weight over 36 to 40 weeks – comparable to results seen with semaglutide ... injections. Companies like Septerna ...

Wegovy (semaglutide) and Zepbound (tirzepatide) are prescription injections that are FDA-approved ... It will also depend on how your body responds to the medication. Ozempic and Mounjaro are ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high ...

Now, you’re considering weight loss injections but are unsure where to start ... Developed by medical experts, this program is tailored to your unique body, lifestyle, and goals. Compounded ...